Invention Grant
- Patent Title: Canine amniotic membrane-derived multipotent stem cells
-
Application No.: US14363145Application Date: 2012-12-06
-
Publication No.: US09771555B2Publication Date: 2017-09-26
- Inventor: Kyung Sun Kang , Min Soo Seo , Sang Bum Park
- Applicant: Kang Stem Biotech, Co., LTD.
- Applicant Address: KR Seoul
- Assignee: KANG STEM BIOTECH, CO., LTD.
- Current Assignee: KANG STEM BIOTECH, CO., LTD.
- Current Assignee Address: KR Seoul
- Agency: Chalker Flores, LLP
- Agent Chainey P. Singleton; Edwin S. Flores
- Priority: KR10-2011-0129818 20111206
- International Application: PCT/KR2012/010538 WO 20121206
- International Announcement: WO2013/085303 WO 20130613
- Main IPC: A61K35/50
- IPC: A61K35/50 ; C12N5/074 ; C12N5/0735 ; C12N5/0775 ; C12N5/079 ; C12N5/077 ; G01N33/569
Abstract:
The present invention relates to canine amniotic membrane-derived multipotent stem cells (cAM-MSCs) and preparation method thereof. More particularly, the present invention relates to canine amniotic membrane-derived multipotent stem cells, which show negative immunological properties on human markers CD3, CD11c, CD28, CD34, CD38, CD41a, CD45, and CD62L and positive immunological properties on human markers CD90 and CD105, and have the ability to be maintained in an undifferentiated state for 20 passages or more and the ability to be differentiated into fat, bones, nerves, cartilage, etc.
Public/Granted literature
- US20140322182A1 Canine Amniotic Membrane-Derived Multipotent Stem Cells Public/Granted day:2014-10-30
Information query
IPC分类:
